The Medical Letter on Drugs and Therapeutics
FROM
ISSUE884
ISSUE884
November 27, 1992
Cefpodoxime Proxetil - A New Oral Cephalosporin
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Cefpodoxime Proxetil - A New Oral Cephalosporin
November 27, 1992 (Issue: 884)
Cefpodoxime proxetil (Vantin - Upjohn), a new third-generation oral cephalosporin, has been approved for marketing by the US Food and Drug Administration. It is available for twice-daily treatment of pharyngitis, upper and lower respiratory...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.